Inventor profile of:

ROGER A. SABBADINI

City:

LAKESIDE, California

Country:

United States

Published Applications:

55

Last publication date:

2015-07-23

Top Assignees for applications by ROGER A. SABBADINI

The entities that hold a legal rights for patent applications filed by inventor SABBADINI ROGER A.:

Recent patent applications by SABBADINI ROGER A.

ROGER A. SABBADINI from LAKESIDE, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-07-23
US20150203570A1
Chemistry; metallurgy

PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO SPHINGOSINE-1-PHOSPHATE

#2 | 2015-06-04
US20150152172A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR BINDING CYSTEINYL LEUKOTRIENES (CYSLTS) FOR TREATMENT OF DISEASE

#3 | 2015-01-29
US20150031055A1
Chemistry; metallurgy

NOVEL BIOACTIVE LIPID DERIVATIVES, AND METHODS OF MAKING AND USING THE SAME

#4 | 2014-07-17
US20140199293A1
Chemistry; metallurgy

HUMANIZED ANTIBODY COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID

#5 | 2014-07-03
US20140186339A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND CONDITIONS

#6 | 2013-12-26
US20130344087A1
Chemistry; metallurgy

COMBINATIONS OF ANTI-S1P ANTIBODIES AND SHPINGOLIPID PATHWAY INHIBITORS

#7 | 2013-11-14
US20130302831A1
Physics

METHODS AND KITS FOR DETECTING AND DIAGNOSING NEUROTRAUMA

#8 | 2013-10-03
US20130261287A1
Chemistry; metallurgy

ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY CRYSTAL STRUCTURES

#9 | 2013-08-08
US20130202586A1
Human necessities

STEM CELL THERAPY USING INHIBITORS OF LYSOPHOSPHATIDIC ACID

#10 | 2013-02-07
US20130034545A1
Chemistry; metallurgy

TREATMENT OF TRAUMATIC BRAIN INJURY USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

#11 | 2012-10-04
US20120252099A1
Chemistry; metallurgy

Immunogenic minicells and methods of use

#12 | 2012-08-02
US20120195901A1
Physics

Compositions and Methods for Binding Lysophosphatidic Acid

#13 | 2012-06-07
US20120142079A1
Chemistry; metallurgy

MINICELL BASED DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS

#14 | 2012-05-31
US20120135503A1
Chemistry; metallurgy

MINICELL BASED DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS

#15 | 2012-04-05
US20120082665A1
Chemistry; metallurgy

Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

#16 | 2012-01-19
US20120014946A1
Chemistry; metallurgy

PREVENTION AND TREATMENT OF PAIN USING MONOCLONAL ANTIBODIES AND ANTIBODY FRAGMENTS TO LYSOPHOSPHATIDIC ACID

#17 | 2012-01-19
US20120014944A1
Chemistry; metallurgy

Prevention and treatment of pain using antibodies to lysophosphatidic acid

#18 | 2011-11-17
US20110281330A1
Chemistry; metallurgy

Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds

#19 | 2011-09-01
US20110212088A1
Chemistry; metallurgy

ANTI-PAF ANTIBODIES

#20 | 2011-05-19
US20110118443A1
Chemistry; metallurgy

Antibody design using anti-lipid antibody crystal structures

#21 | 2011-03-31
US20110076267A1
Chemistry; metallurgy

Humanized antibody compositions and methods for binding lysophosphatidic acid

#22 | 2011-03-17
US20110064744A1
Chemistry; metallurgy

PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

#23 | 2011-02-24
US20110044990A1
Chemistry; metallurgy

ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY CRYSTAL STRUCTURES

#24 | 2011-01-27
US20110020319A1
Chemistry; metallurgy

Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents

#25 | 2010-11-18
US20100292443A1
Physics

Humanized platelet activating factor antibody design using anti-lipid antibody templates

#26 | 2010-09-09
US20100226916A1
Human necessities

Compositions and methods for treating ocular diseases and conditions

#27 | 2010-04-22
US20100098700A1
Chemistry; metallurgy

Pharmaceutical compositions for binding sphingosine-1-phosphate

#28 | 2010-02-11
US20100034814A1
Chemistry; metallurgy

Compositions and methods for binding lysophosphatidic acid

#29 | 2010-01-07
US20100003242A1
Chemistry; metallurgy

Compositions and methods for binding sphingosine-1-phosphate

#30 | 2009-09-03
US20090220523A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS

#31 | 2009-06-11
US20090148443A1
Chemistry; metallurgy

Humanized antibodies and compositions for binding sphingosine-1-phosphate

#32 | 2009-05-28
US20090137037A1
Chemistry; metallurgy

Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate

#33 | 2009-05-28
US20090136483A1
Physics

Compositions and methods for binding lysophosphatidic acid

#34 | 2009-05-21
US20090130100A1
Chemistry; metallurgy

Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate

#35 | 2009-05-21
US20090130099A1
Chemistry; metallurgy

Humanized antibodies and compositions for binding sphingosine-1-phosphate

#36 | 2009-03-19
US20090074789A1
Human necessities

Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions

#37 | 2009-03-19
US20090074720A1
Chemistry; metallurgy

METHODS FOR DECREASING IMMUNE RESPONSE AND TREATING IMMUNE CONDITIONS

#38 | 2009-01-08
US20090011490A1
Chemistry; metallurgy

Immunogenic minicells and methods of use

#39 | 2009-01-08
US20090010922A1
Chemistry; metallurgy

Compositions and methods for binding sphingosine-1-phosphate

#40 | 2008-09-04
US20080213274A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY, AND NEOVASCULARIZATION CONDITIONS OF THE EYE

#41 | 2008-06-19
US20080145360A1
Physics

Immune-derived moieties reactive against lysophosphatidic acid

#42 | 2008-06-12
US20080138334A1
Physics

Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same

#43 | 2008-04-17
US20080090303A1
Physics

Methods and reagents for detecting bioactive lipids

#44 | 2007-12-06
US20070281320A1
Chemistry; metallurgy

Bioactive lipid derivatives, and methods of making and using same

#45 | 2007-12-06
US20070280933A1
Chemistry; metallurgy

Methods for decreasing immune response and treating immune conditions

#46 | 2007-09-13
US20070212348A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

#47 | 2007-06-28
US20070148168A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions

#48 | 2007-05-31
US20070122881A1
Chemistry; metallurgy

Rhamnose-inducible expression constructs and methods

#49 | 2007-02-27
US10156902
-

Eubacterial minicells and their use as vectors for nucleic acid delivery and expression

#50 | 2007-01-30
US10820582
-

Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

#51 | 2006-08-03
US20060171946A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of hyperproliferative diseases

#52 | 2005-10-13
US20050226862A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders and for identifying agents therapeutic therefor

#53 | 2005-07-07
US20050147590A1
Chemistry; metallurgy

Immunogenic minicells and methods of use

#54 | 2005-04-19
US10028156
-

Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor

#55 | 2005-02-22
US10029401
-

Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor

InventorID:

78019 ⎘